• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

    50.92 +0.17 (+0.33%)
    Delayed Quote Updated: 10:57 AM EDT, Oct 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

    < Previous 1 2 3 4 5 6 7 Next >
    News headline image
    Hibsago (bepirovirsen) Approved in the US for the Treatment of Chronic Hepatitis B (CHB)
    From GSK plc
    Via Business Wire
    News headline image
    Jemperli (dostarlimab-gxly) approved in US as first and only immunotherapy for adults with MSI-H/dMMR locally advanced rectal cancer
    From GSK plc
    Via Business Wire
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AtaiBeckley Inc. (Nasdaq – ATAI), Distribution Solutions Group, Inc. (Nasdaq – DSGR), Cross Country Healthcare, Inc. (Nasdaq – CCRN), Nuvalent, Inc. (Nasdaq – NUVL)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    Core Restore Founder Ann Peets Announces Bladder Leak Treatments In Charleston
    Via Press Release Distribution Service
    Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
    Via Investor Brand Network
    BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Targets Next Generation of DNA Damage Response Cancer Therapies
    Via Investor Brand Network
    Topics Artificial Intelligence
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Arcosa, Inc. (NYSE – ACA), Fathom Holdings Inc. (Nasdaq – FTHM), Nuvalent, Inc. (Nasdaq – NUVL), Dana Incorporated (NYSE – DAN)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    Next-Generation DNA Repair Inhibitors Could Capture Billions in Emerging Market
    From BioMedWire
    Via GlobeNewswire
    News headline image
    Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
    From GSK plc
    Via Business Wire
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nuvalent, Inc. (Nasdaq – NUVL), Dana Incorporated (NYSE – DAN), SUNation Energy, Inc. (Nasdaq – SUNE), Taylor Morrison Home Corporation (NYSE - TMHC)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nuvalent, Inc. (Nasdaq – NUVL), SUNation Energy, Inc. (Nasdaq – SUNE), Organon & Co. (NYSE – OGN), Taylor Morrison Home Corporation (NYSE – TMHC)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    News headline image
    Julie Bowen and Ty Burrell team up with GSK to raise awareness about meningitis risks for teens and young adults
    From GSK plc
    Via Business Wire
    News headline image
    GSK’s RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 18–49 Years at Increased Risk
    From GSK plc
    Via Business Wire
    News headline image
    Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract
    From Bora Pharmaceuticals Co., Ltd.
    Via Business Wire
    News headline image
    GSK’s AREXVY Associated With Reductions in Certain RSV-Related Risks Including Heart Attack, Stroke and Severe Flare-Ups of COPD and Asthma, Real World Study Shows
    From GSK plc
    Via Business Wire
    News headline image
    GSK Awards $2M in COiMMUNITY Initiative Grants to Help Close Vaccination Gaps, Commits $3M for 2026
    From GSK plc
    Via Business Wire
    News headline image
    GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million
    From GSK plc
    Via Business Wire
    News headline image
    Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma
    From GSK plc
    Via Business Wire
    News headline image
    Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma
    From GSK plc
    Via Business Wire
    News headline image
    New Local Data in GSK and IQVIA's Vaccine Track Supports Smarter Public Health Action at the Community Level
    From GSK plc
    Via Business Wire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of GSK plc – GSK
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    GSK sponsors 2025 National Senior Games as part of Sideline RSV campaign to raise awareness of RSV in older adults
    From GSK plc
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.